AMETEK (NYSE:AME) released its quarterly earnings data on Tuesday. The technology company reported $1.05 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.02, Briefing.com reports. The company had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.32 billion. AMETEK had a return on equity of 18.56% and a net margin of 16.14%. The company’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.83 earnings per share.

Shares of AME traded up $2.20 on Tuesday, hitting $90.75. The company’s stock had a trading volume of 1,561,900 shares, compared to its average volume of 1,203,816. The firm has a market capitalization of $20.34 billion, a P/E ratio of 27.58, a PEG ratio of 2.28 and a beta of 1.24. The company has a quick ratio of 1.27, a current ratio of 1.91 and a debt-to-equity ratio of 0.53. AMETEK has a fifty-two week low of $63.14 and a fifty-two week high of $92.30. The business has a 50 day moving average price of $88.98.

AME has been the topic of a number of recent research reports. Zacks Investment Research downgraded Essential Properties Realty Trust from a “buy” rating to a “hold” rating in a report on Thursday, June 13th. BMO Capital Markets raised TMAC Resources from a “market perform” rating to an “outperform” rating in a report on Thursday, May 2nd. Morgan Stanley set a $226.00 price objective on S&P Global and gave the company a “hold” rating in a report on Friday, May 3rd. DA Davidson raised Domtar from a “neutral” rating to a “buy” rating in a report on Thursday, May 2nd. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 150 ($1.96) price objective on shares of Tharisa in a report on Wednesday, May 15th. Fifteen investment analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and an average target price of $91.50.

In other news, Director Thomas A. Amato sold 1,790 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $83.57, for a total value of $149,590.30. Following the transaction, the director now directly owns 9,370 shares of the company’s stock, valued at approximately $783,050.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Dennis K. Williams sold 1,570 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $87.00, for a total value of $136,590.00. The disclosure for this sale can be found here. Insiders sold a total of 93,370 shares of company stock worth $8,072,702 over the last three months. 0.80% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Cornerstone Advisors Inc. boosted its holdings in shares of AMETEK by 55.2% in the 1st quarter. Cornerstone Advisors Inc. now owns 388 shares of the technology company’s stock worth $32,000 after acquiring an additional 138 shares in the last quarter. Berman Capital Advisors LLC boosted its holdings in shares of AMETEK by 51.3% in the 2nd quarter. Berman Capital Advisors LLC now owns 454 shares of the technology company’s stock worth $41,000 after acquiring an additional 154 shares in the last quarter. Liberty Wealth Management LLC acquired a new position in shares of AMETEK in the 1st quarter worth approximately $40,000. Ibex Wealth Advisors acquired a new position in AMETEK during the 2nd quarter worth $52,000. Finally, Legacy Advisors LLC acquired a new position in AMETEK during the 2nd quarter worth $55,000. 85.82% of the stock is currently owned by institutional investors and hedge funds.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

Read More: Inflation

Earnings History for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.